Published
UROONCO PCa chief editor Dr. Giancarlo Marra talks to Prof. Fred Saad on the ARANOTE study: Darolutamide in combination with androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer (mHSPC).
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
09:21
Plus Therapeutics (NASDAQ: PSTV) Interview at the NYSE | Fintech TV Exclusive
-
08:12
మూడో కన్ను తెరిచిన అఘోర..! | Aghora Exclusive Full Interview | Sri Swamy Siddhayogi | SumanTV
-
05:51
New Study: Enhanced Telehealth for Prostate Cancer Patients
-
13:03
NEJM Interview: Andrew Hantel on a source of discrimination against some patients in cancer resea...
-
12:01
Exclusive Interview with Dr. Yuman Fong Innovations in Cancer Surgery
-
11:18
Updates on the ARANOTE Trial: PSA Response with Darolutamide Plus ADT in Patients with mHSPC
-
11:52
CRT NEXT Study Explained: 2‑Lead CRT‑DX vs. 3‑Lead CRT‑D | Interview with Dr. Mauro Biffi
-
07:45
AIM Higher Clinical Study for Patients
-
09:41
Unexpected Findings in Study of Gene Mutations for Pediatric Cancer Patients
-
09:08
First-in-human JNJ-79635322 trispecific antibody study in RRMM patients: Initial phase 1 results
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
